Ubs Asset Management Americas Inc Novo Nordisk A S Transaction History

Ubs Asset Management Americas Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $380,082 - $444,115	-7,623 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $4,563 - $5,129	-96 Reduced 1.24%	7,623 $394,000
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $16,142 - $18,102	-345 Reduced 4.28%	7,719 $0
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $83,957 - $95,312	-1,811 Reduced 18.34%	8,064 $0
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $1.53 Million - $1.74 Million	-36,775 Reduced 78.83%	9,875 $454,000
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $502,202 - $550,317	-10,740 Reduced 18.71%	46,650 $0
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $198,330 - $225,780	4,478 Added 8.46%	57,390 $0
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $114,533 - $137,326	2,362 Added 4.67%	52,912 $0
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $198,580 - $224,483	4,178 Added 9.01%	50,550 $0
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $1.91 Million - $2.28 Million	46,372	46,372 $0

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $240B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.